R. Letestu et al., Existence of a differentiation blockage at the stage of a megakaryocyte precursor in the thrombocytopenia and absent radii (TAR) syndrome, BLOOD, 95(5), 2000, pp. 1633-1641
The thrombocytopenia and absent radii (TAR) syndrome is a rare disease asso
ciating bilateral radial agenesis and congenital thrombocytopenia, Here, we
investigated in vitro megakaryocyte (MK) differentiation and expression of
c-mpl in 6 patients. Using blood or marrow CD34(+) cells, the colony-formi
ng unit (CFU)-MK number was markedly reduced. CD34(+) cells were also cultu
red in liquid medium in the presence of a combination of 3 cytokines (stem
cell factor, interleukin-3, and interleukin-6) or megakaryocyte growth and
development factor (PEG-rHuMGDF) with or without SCF, In the presence of PE
G-rHuMGDF, the majority of mature megakaryocytes (CD41 high, CD42 high) und
erwent apoptosis, This phenomenon was also observed in cultures stimulated
by three cytokines, However, this last combination of cytokines allowed a m
ore complete terminal MK differentiation. Surprisingly, a homogeneous popul
ation of CD34(-)CD41(+)CD42(-) cells accumulated during the cultures. This
population was unable to differentiate along the myeloid pathways. This res
ult suggests that a fraction of MK cells is unable to differentiate in the
TAR syndrome, We subsequently investigated whether this could be related to
an abnormality in c-mpl, No mutation or rearrangement in the c-mpl gene wa
s found by Southern blots or by sequencing of the c-mpl coding region and i
ts promoter in any of the patients. Using Western blot analysis, a decrease
d level of MpI was found in patient platelets. A decreased level of c-mpl m
essenger RNA in TAR platelets was also detected with a lower c-mpl-P to c-m
pl-K ratio in comparison to adult platelets. Altogether, these results demo
nstrate that the thrombocytopenia of the TAR syndrome is associated with a
dysmegakaryocytopoiesis characterized by cells blocked at an early stage of
differentiation. (C) 2000 by The American Society of Hematology.